Where Life Science Innovation Moves Forward
iC³ Life Science and Healthcare Innovation Summit:
September 24-25, 2026 - Arlington, TX
Meet Veristat at RAPS Convergence 2026
August 26, 2026
Where Regulatory Strategy Meets What’s Next
RAPS Convergence US: September 15-17, 2026 – Charlotte, NC
Meet Veristat at DPHARM 2026
August 26, 2026
Turning Clinical Trial Innovation Into Action
DPHARM: September 15-16, 2026 – Boston, MA
SCDM ANNUAL CONFERENCE 2026
July 24, 2026
Meet Veristat at the SCDM Annual Conference
September 14–17, 2026 – Raleigh, North Carolina
June 22-25, 2026 – San Diego, CA
Connect with Veristat at OCT East Coast
April 30, 2026
May 12-13, 2026 – New Brunswick, NJ
Meet Veristat at the ASGCT Annual Meeting
April 30, 2026
May 11-15, 2026 – Boston, MA
🔬 Where Cell and Gene Therapy Moves Forward
Veristat is pleased to attend the ASGCT Annual Meeting, where leaders across cell and gene therapy come together to share progress, tackle challenges, and shape what comes next. As programs advance through early-phase development, the stakes are high. Scientific complexity, evolving regulatory expectations, and the need for clear, defensible data all converge at this stage.
Our team looks forward to connecting with sponsors and innovators to discuss how Veristat supports cell and gene therapy programs with integrated regulatory, clinical, and biostatistical expertise. The focus is simple: make development capital count and enable faster, more confident decisions as therapies move closer to patients.